Novartis in spotlight again over Japan study practices | PharmaBoardroom
written on 14.02.2014
Tags:
,

Novartis in spotlight again over Japan study practices

TAGS: ,

The leukemia drug was the subject of a multi-center, investigator-initiated joint study begun in 2012, which aimed to gather information on side-effects in chronic myeloid leukemia (CML) patients receiving it or other tyrosine kinase inhibitors.

Latest Report